Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (661-670 of 776) with videos related to

Pageof 78
Sort By:
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2025
Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer's disease in clinical and community cohortsJun Wang, Shan Huang, Guoyu Lan, et al.
Annals of Neurology|January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageingChristopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Brain : a Journal of Neurology|September 22, 2018
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's diseaseMiguel Ángel Araque Caballero, Marc Suárez-Calvet, Marco Duering, et al.
Neuron|July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial AbetaPaul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Science China. Life Sciences|May 11, 2026
Proteomic comparison of human neural cell-derived extracellular vesicles and parental cells from Alzheimer's disease and cognitively normal individualsJia-Yan Xin, Jie Liu, Hao-Min Dong, et al.
Pageof 78

Showing results (661-670 of 776) with videos related to

Sort By:
Pageof 78
The Journal of Prevention of Alzheimer'S Disease|January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scansAzadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 29, 2025
Diagnostic accuracy of plasma p-tau217/Aβ42 for Alzheimer's disease in clinical and community cohortsJun Wang, Shan Huang, Guoyu Lan, et al.
Annals of Neurology|January 23, 2014
Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageingChristopher C Rowe, Pierrick Bourgeat, Kathryn A Ellis, et al.
Acta Neuropathologica Communications|September 30, 2021
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
Brain : a Journal of Neurology|September 22, 2018
White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's diseaseMiguel Ángel Araque Caballero, Marc Suárez-Calvet, Marco Duering, et al.
Neuron|July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial AbetaPaul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
JAMA Neurology|January 27, 2015
Factors associated with the onset and persistence of post-lumbar puncture headacheAndrés E Monserrate, Davis C Ryman, Shengmei Ma, et al.
Nature Medicine|November 10, 2022
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive declineRik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Science China. Life Sciences|May 11, 2026
Proteomic comparison of human neural cell-derived extracellular vesicles and parental cells from Alzheimer's disease and cognitively normal individualsJia-Yan Xin, Jie Liu, Hao-Min Dong, et al.
Pageof 78